المؤلفون: Dennis L. Sprecher, Barbara A. Fielding, Stephen O'Rahilly, Keith N. Frayn, Duncan Richards, Samar Basu, Fredrik Karpe, Priti S. Hegde, Timothy M. Willson, Peter R. Murgatroyd, Zeke Fang, Niall R. Moore, Jay Strum, Theodore M. Danoff, Leli Sarov-Blat, Jane Cheeseman, Pauline Sutton, David G. Hassall, Sandy M. Humphreys, Eric Olson, Ulf Risérus, Tony G. Johnson, Aixue Liu, Sandra Hirschberg

المصدر: Diabetes. 57:332-339

مصطلحات موضوعية: Adult, Male, Agonist, medicine.medical_specialty, Adolescent, Apolipoprotein B, medicine.drug_class, Endocrinology, Diabetes and Metabolism, Peroxisome proliferator-activated receptor, Biology, medicine.disease_cause, GW501516, Placebos, chemistry.chemical_compound, Double-Blind Method, Internal medicine, Internal Medicine, medicine, Humans, Obesity, PPAR delta, Triglycerides, Apolipoproteins B, chemistry.chemical_classification, Cholesterol, Cholesterol, HDL, Fatty Acids, Elafibranor, Middle Aged, medicine.disease, Magnetic Resonance Imaging, Oxidative Stress, Thiazoles, Endocrinology, chemistry, biology.protein, Metabolic syndrome, Oxidation-Reduction, Oxidative stress

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501cd118af2c29620b3e29bd31a1edc2
https://doi.org/10.2337/db07-1318